Minot De Blois Advisors LLC Astrazeneca PLC Transaction History
Minot De Blois Advisors LLC
- $109 Billion
- Q4 2024
A detailed history of Minot De Blois Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Minot De Blois Advisors LLC holds 75 shares of AZN stock, worth $5,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75Holding current value
$5,610% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,353Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.51 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.07 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.81 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.77 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.8 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $232B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...